Targeted oncology, a promising field within cancer research, focuses on treatments tailored to individual patients based on their genetic makeup, tumor characteristics, and other factors. This personalized approach offers the potential for more effective and less toxic therapies compared to traditional treatments. Targeted therapies often involve drugs that specifically target molecules involved in cancer growth and progression, such as certain proteins or genetic mutations. Advancements in genomics and molecular biology have facilitated the development of these therapies, allowing oncologists to better match treatments to the unique molecular profiles of patients' tumors. As research in targeted oncology continues to evolve, it holds great promise for improving outcomes and quality of life for cancer patients.



Title : Multiplexed biosensor detection of cancer biomarkers
Michael Thompson, University of Toronto, Canada
Title : Nanomedicine in over 45,000 patients and no cancer
Thomas Jay Webster, Brown University, United States